SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-17-001421
Filing Date
2017-08-04
Accepted
2017-08-04 18:23:00
Documents
2
Period of Report
2017-08-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT e616442_4-proteon.html 4  
1 OWNERSHIP DOCUMENT e616442_4-proteon.xml 4 6933
2 e616442_ex99.htm EX-99 3641
  Complete submission text file 0001193805-17-001421.txt   12539
Mailing Address 780 THIRD AVENUE, 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017 2125511600
DEERFIELD MANAGEMENT CO (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 171009713

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 171009714

Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)